Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Financial Results and Host Conference Call on February 27,

    Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2012
       Financial Results and Host Conference Call on February 27, 2013

PR Newswire

POINT RICHMOND, Calif., Feb. 21, 2013

POINT RICHMOND, Calif., Feb. 21, 2013 /PRNewswire/ -- Transcept
Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company
focused on the development and commercialization of proprietary products that
address important therapeutic needs in the field of neuroscience, today
announced that the company will host a conference call on Wednesday, February
27, 2013, at 4:30 p.m. Eastern Time to discuss its fourth quarter and full
year 2012 financial results. The conference call will follow the release of
the Transcept fourth quarter and full year 2012 financial results after the
close of market that day.

Conference Call Information
 Date: Wednesday, February 27, 2013
 Time: 4:30 p.m. ET
 Dial-in (U.S.): 877-638-4558
 Dial-in (International): 914-495-8537

A simultaneous webcast of the conference call will be available on the
Investors section of the Transcept website at www.transcept.com. A replay of
this webcast will be available on the website shortly after the conclusion of
the call through March 31, 2013.

About Transcept
Transcept Pharmaceuticals, Inc.is a specialty pharmaceutical company focused
on the development and commercialization of proprietary products that address
important therapeutic needs in the field of neuroscience. Intermezzo®
(zolpidem tartrate) sublingual tablet C-IV is the firstFDAapproved Transcept
product.PurduePharma holds commercialization and development rights for
Intermezzo in the United States. For further information about Transcept,
please visit www.transcept.com. For information about Intermezzo, please visit
www.MyIntermezzo.com.

Contact:
Transcept Pharmaceuticals, Inc.
Greg Mann
Sr. Director, Corporate Communications
(510) 215-3567
gmann@transcept.com

SOURCE Transcept Pharmaceuticals, Inc.

Website: http://www.transcept.com
Website: http://www.myintermezzo.com